Role of structural variations of polysaccharide antigens in the pathogenicity of Gram-negative bacteria

Clinical Microbiology and Infection

Volumn 14, Issue 3, 2008, Pages 200-206

  Lukacova, Magda ^a   Barak I ^a   Kazar J ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Antigens; Lipopolysaccharide; Mutation; Outer membrane; Phase variation; Review

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL POLYSACCHARIDE; GLYCOSYLTRANSFERASE; O ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; Q FEVER VACCINE; VIRULENCE FACTOR;

BACTERIAL OUTER MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CAMPYLOBACTER JEJUNI; CELL LINE; COXIELLA BURNETII; DIAGNOSTIC VALUE; DNA SEQUENCE; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HOST; HUMAN; HYDROPHOBICITY; IMMUNE SYSTEM; MOLECULAR MECHANICS; NEISSERIA; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; Q FEVER; REVIEW; SEROLOGY; ZYGOTE;

BACTERIA (MICROORGANISMS); COXIELLA BURNETII; NEGIBACTERIA;

EID: 39049112142     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01876.x     Document Type: Review

References (52)

1. Gronow S, Brade H. Lipopolysaccharide biosynthesis: Which steps do bacteria need to survive? J Endotoxin Res 2001; 7: 3-23.
2. Lerouge I, Vanderleyden J. O-antigen structural variation: Mechanism and possible roles in animal/plant-microbe interactions. FEMS Microbiol Rev 2001; 26: 17-47.
3. Hallet B. Playing Dr Jekyll and Mr Hyde: Combined mechanisms of phase variation in bacteria. Curr Opin Microbiol 2001; 4: 570-581.
4. Radman M. Enzymes of evolutionary change. Nature 1999; 401: 866-869.
5. Van der Woude M, Bäumler AJ. Phase and antigenic variation in bacteria. Clin Microbiol Rev 2004; 17: 581-611.
6. Henderson IR, Owen P, Nataro JP. Molecular switches-the ON and OFF of bacterial phase variation. Mol Microbiol 1999; 33: 919-932.
7. Saunders NJ, Peden JF, Hood DW, Moxon ER. Simple sequence repeats in the Helicobacter pylori genome. Mol Microbiol 1998; 27: 1091-1098.
8. Power PM, Roddam LF, Rutter K, Fitzpatrick SZ, Srikhanta YN, Jennings MP. Genetic characterization of pilin glycosylation and phase variation in Neisseria meningitidis. Mol Microbiol 2003; 49: 833-847.
9. Berrington AW, Tan YC, Srikhanta Y etal. Phase variation in meningococcal lipooligosaccharide biosynthesis genes. FEMS Immunol Med Microbiol 2002; 34: 267-275.
10. Tzeng Y-L, Stephens DS. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2000; 2: 687-700.
11. Martin P, van de Ven T, Mouchel N, Jeffries AC, Hood DW, Moxon ER. Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: Evidence for a novel mechanism of phase variation. Mol Microbiol 2003; 50: 245-257.
12. Taha M-K, Degmane A-E, Antignac A, Zarantonelli ML, Larribe M, Alonso J-M. The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiol 2002; 10: 376-382.
13. Schneider H, Hammack CA, Apicella MA, Griffiths JM. Instability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae. Infect Immun 1988; 56: 942-946.
14. Van Putten JPM. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J 1993; 12: 4043-4051.
15. Packiam M, Shell DM, Liu SV et al. Differential expression and transcriptional analysis of the α-2,3-sialyltransferase gene in pathogenic Neisseria spp. Infect Immun 2006; 74: 2637-2650.
16. Fox KL, Yldirim HH, Deadman ME, Schweda EKH, Moxon ER, Wood DW. Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats in Haemophilus influenzae: Identification of a gene for adding O-acetyl groups. Mol Microbiol 2005; 58: 207-216.
17. Zaleski P, Wojciechowski M, Piekarovicz A. The role of Dam methylation in phase variation of Haemophilus influenzae genes involved in defence against phage infection. Microbiology 2005; 151: 3361-3369.
18. Peak IRA, Jennings MP, Hood DW, Bisercic M, Moxon ER. Tetrameric repeat units associated with virulence factor phase variation in Haemophilus also occur in Neisseria spp. and Moraxella catarrhalis. FEMS Microbiol Lett 1996; 137: 109-114.
19. Peak IRA, Jennings MP, Hood DW, Moxon ER. Tetranucleotide repeats identify novel virulence determinant homologues in Neisseria meningitidis. Microb Pathog 1999; 26: 13-23.
20. Weiser JN, Lindberg AA, Manning EJ, Hansen EJ, Moxon ER. Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun 1989; 57: 3045-3052.
21. Weiser JN, Williams A, Moxon ER. Phase variable lipopolysaccharide structure enhances the invasive capacity of Haemophilus influenzae. Infect Immun 1990; 58: 3455-3457.
22. Erwin AL, Bonthuis PJ, Geelhood JL et al. Heterogeneity in tandem octanucleotides within Haemophilus influenzae lipopolysaccharide biosynthetic gene losA affect serum resistance. Infect Immun 2006; 74: 3408-3414.
23. Torres-Cruz J, van der Woude M. Slipped-strand mispairing can function as a phase variation mechanism in Escherichia coli. J Bacteriol 2003; 185: 6990-6994.
24. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol 2001; 40: 769-777.
25. Salaün L, Saunders NJ. Population-associated differences between the phase variable LPS biosynthetic genes of Helicobacter pylori. BMC Microbiol 2006; 6: 79.
26. Appelmelk BJ, Shiberu B, Trinks C et al. Phase variation in Helicobacter pylori lipopolysaccharide. Infect Immun 1998; 66: 70-76.
27. Logan SM, Conian JW, Monteiro MA, Wakarchuk WW, Altman E. Functional genomics of Helicobacter pylori: Identification of a β-1,4-galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol 2000; 35: 1156-1167.
28. Tannaes T, Dekker N, Bukholm G, Bilsma JJ, Appelmelk BJ. Phase variation in the Helicobacter pylori phospholipase. A gene and its role in acid adaptation. Infect Immun 2001; 69: 7334-7340.
29. Cowly SC, Gray CJ, Nano FE. Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis. FEMS Microbiol Lett 2000; 182: 63-67.
30. Kieffer TL, Cowley S, Nano FE, Elkins KL. Franciscella novicida LPS has greater immunological activity in mice than F.tularensis LPS, and contributes to F.novicida murine pathogenesis. Microb Infect 2003; 5: 397-403.
31. Lüneberg E, Mayer B, Daryab N et al. Chromosomal insertion and excision of a 30kb unstable genetic element is responsible for phase variation of lipopolysaccharide and other virulence determinants in Legionella pneumophila. Mol Microbiol 2001; 39: 1259-1271.
32. Schnaitman CA, Klena JD. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 1993; 57: 655-682.
33. Parker CT, Kloser AW, Schneitman CA, Stein MA, Gottesman S, Gibson BW. Role of the rfaG and rfaP genes in determining the lipopolysaccharide core structure and cell surface properties of Escherichia coli K-12. J Bacteriol 1992; 174: 2525-2538.
34. Laird MW, Kloser AW, Misra R. Assembly of LamB and OmpF in deep rough lipopolysaccharide mutants of Escherichia coli K-12. J Bacteriol 1994; 178: 2259-2264.
35. Borneleit P, Blechschmidt B, Kleber H-P. Lipopolysaccharide-protein interactions: Determination of dissociation constants by affinity electrophoresis. Electrophoresis 1989; 10: 848-852.
36. Diedrich DL, Stein MA, Schnaitman CA. Associations of Escherichia coli K-12 OmpF trimers with rough and smooth lipopolysaccharides. J Bacteriol 1990; 172: 5307-5311.
37. Helander IM, Vaara M, Sukupolvi S et al. rfa mutants of Salmonella typhimurium. Eur J Biochem 1989; 185: 541-546.
38. Moran AP, Helander IM, Kosunen TU. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol 1992; 174: 1370-1377.
39. Kazár J. Coxiella burnetii infection. Ann NY Acad Sci 2005; 1063: 105-114.
40. Peacock MG, Philip RN, Williams JC, Faulkner RS. Serological evaluation of Qfever in humans: Enhanced phaseI titers of immunoglobulinsG and A are diagnostic for Qfever endocarditis. Infect Immun 1983; 41: 1089-1098.
41. Lukáčová M, Kazár J, Gajdošová E, VavrekováM. Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging. FEMS Microbiol Lett 1993; 113: 285-290.
42. Kazár J, Brezina R, Schramek S, Úrvölgyi J, Pospíšil V, KováčováE. Virulence, antigenic properties and physico-chemical characteristic of Coxiella burnetii strains with different chick embryo yolk sac passage history. Acta Virol 1974; 18: 434-442.
43. Quevedo Diaz MA, Lukáčová M. Immunological consequences of Coxiella burnetii phase variation. Acta Virol 1998; 42: 181-185.
44. Hackstadt T. Steric hindrance of antibody binding to surface proteins of Coxiella burnetii by phaseI lipopolysaccharide. Infect Immun 1988; 56: 802-807.
45. LukáčováM, Kazár J, Gajdošová E. Coxiella burnetii phaseI and II proteins studied by SDS-PAGE. Acta Virol 1994; 38: 263-267.
46. Hotta A, Kawamura M, To H et al. Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies. Infect Immun 2002; 70: 4747-4749.
47. Vodkin MH, Williams JC. Overlapping deletions in two spontaneous phase variants of Coxiella burnetii. J Gen Microbiol 1986; 132: 2587-2594.
48. Hoover TA, Culp DW, Vodkin MH, Williams JC, Thompson HA. Chromosomal DNA deletions explain phenotypic characteristic of two antigenic variants, phaseII and RSA514 (Crazy), of the Coxiella burnetii Nine Mile strain. Infect Immun 2002; 70: 6726-6733.
49. Denison AM, Massung RF, Thompson HA. Analysis of the O-antigen biosynthesis regions of phaseII isolates of Coxiella burnetii. FEMS Microbiol Lett 2007; 267: 102-107.
50. Beare AP, Samuel JE, Howe D, Virtaneva K, Porcella SF, Heinzen RA. Genetic diversity of the Qfever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons. J Bacteriol 2006; 188: 2309-2324.
51. Hitchcock PJ, Leive L, Makela PE, Rietchel ET, Strittmatter W, Morrison DC. Lipopolysaccharide nomenclature-past, present, and future. J Bacteriol 1986; 166: 699-705.
52. LesnáJ, Lesný M, Lukáčová M, Kazár J. Reactogenicity and immunogenicity of three Qfever chemovaccine preparations. In: Kazár J, Raoult R, eds, Proceedings of the IV international symposium on rickettsiae and rickettsial diseases. Bratislava: Slovak Academy of Sciences, 1990; 674-677.